Nonviral gene transfer of hepatocyte growth factor attenuates neurologic injury after spinal cord ischemia in rabbits

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 4, 2006, Pages 941-947

  Shi, Enyi ^a,b   Jiang, Xiaojing ^a   Kazui, Teruhisa ^a   Washiyama, Naoki ^a   Yamashita, Katsushi ^a   Terada, Hitoshi ^a   Bashar, Abul Hasan Muhammad ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; HINDLIMB; HISTOLOGY; MOTONEURON; MOTOR PERFORMANCE; NERVOUS SYSTEM INJURY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; SPINAL CORD ISCHEMIA; VIRUS ENVELOPE;

ANIMALS; GENE TRANSFER TECHNIQUES; HEPATOCYTE GROWTH FACTOR; PARAPLEGIA; RABBITS; SPINAL CORD ISCHEMIA;

EID: 33748764969     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.06.018     Document Type: Article

References (30)

1. Svensson L.G., Crawford E.S., Hess K.R., Coselli J.S., and Safi H. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 17 (1993) 357-370
2. Coselli J.S., LeMaire S.A., Miller III C.C., Schmittling Z.C., Koksoy C., Pagan J., et al. Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis. Ann Thorac Surg 69 (2000) 409-414
3. Aoki M., Morishita R., Taniyama Y., Kida I., Moriguchi A., Matsumoto K., et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 7 (2000) 417-427
4. Koike H., Morishita R., Iguchi S., Aoki M., Matsumoto K., Nakamura T., et al. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene. FASEB J 17 (2003) 779-781
5. Honda S., Kagoshima M., Wanaka A., Tohyama M., Matsumoto K., and Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 32 (1995) 197-210
6. Korhonen L., Sjoholm U., Takei N., Kern M.A., Schirmacher P., Castren E., et al. Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. Eur J Neurosci 12 (2000) 3453-3461
7. Nakamura T., Nawa K., Ichikawa A., Kaise N., and Nishimoto T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224 (1987) 311-316
8. Hayashi K., Morishita R., Nakagami H., Yoshimura S., Hara A., Matsumoto K., et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Ther 8 (2001) 1167-1173
9. Zhang L., Himi T., Morita I., and Murota S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J Neurosci Res 59 (2000) 489-496
10. Yoshimura S., Morishita R., Hayashi K., Kokuzawa J., Aoki M., Matsumoto K., et al. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 39 (2002) 1028-1034
11. Kato N., Nemoto K., Nakanishi K., Morishita R., Kaneda Y., Uenoyama M., et al. Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res 52 (2005) 299-310
12. Shimamura M., Sato N., Oshima K., Aoki M., Kurinami H., Waguri S., et al. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 109 (2004) 424-431
13. Tsuzuki N., Miyazawa T., Matsumoto K., Nakamura T., and Shima K. Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res 23 (2001) 417-424
14. Kaneda Y., Nakajima T., Nishikawa T., Yamamoto S., Ikegami H., Suzuki N., et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6 (2002) 219-226
15. Shi E., Kazui T., Jiang X., Washiyama N., Suzuki K., Yamashita K., et al. NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg 129 (2005) 364-371
16. Shi E., Kazui T., Jiang X., Washiyama N., Yamashita K., Terada H., et al. Intrathecal injection of bone marrow stromal cells attenuates neurologic injury after spinal cord ischemia. Ann Thorac Surg 81 (2006) 2227-2234
17. Tarlov I.M. Acute spinal cord compression paralysis. J Neurosurg 36 (1972) 10-20
18. Mutch W.A., Graham M.R., Halliday W.C., Thiessen D.B., and Girling L.G. Use of neuroanesthesia adjuncts (hyperventilation and mannitol administration) improves neurological outcome after thoracic aortic cross-clamping in dogs. Stroke 24 (1993) 1204-1210
19. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
20. Nakamura Y., Morishita R., Nakamura S., Aoki M., Moriguchi A., Matsumoto K., et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28 (1996) 409-413
21. Jayasankar V., Woo Y.J., Bish L.T., Pirolli T.J., Chatterjee S., Berry M.F., et al. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108 suppl (2003) II230-II236
22. Hashimoto N., Yamanaka H., Fukuoka T., Dai Y., Obata K., Mashimo T., et al. Expression of HGF and cMet in the peripheral nervous system of adult rats following sciatic nerve injury. Neuroreport 12 (2001) 1403-1407
23. Jung W., Castren E., Odenthal M., Vande Woude G.F., Ishii T., Dienes H.P., et al. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 126 (1994) 485-494
24. Maina F., and Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 2 (1999) 213-217
25. Hayashi T., Abe K., Sakurai M., and Itoyama Y. Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res 799 (1998) 311-316
26. Miyazawa T., Matsumoto K., Ohmichi H., Katoh H., Yamashima T., and Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 18 (1998) 345-348
27. Mulligan R.C. The basic science of gene therapy. Science 260 (1993) 926-932
28. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106 (2000) 829-838
29. Baumgartner I., Rauh G., Pieczek A., Wuensch D., Magner M., Kearney M., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 132 (2000) 880-884
30. Morishita R., Aoki M., Hashiya N., Yamasaki K., Kurinami H., Shimizu S., et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 4 (2004) 199-206